Trial intelligence / Profile preview

Epidural vs PCA in Prostatectomy

NCT01367418Phase 3Completed

Sponsor
Örebro University
Start
Sep 2010
Primary completion
Mar 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ropivacaine, sufentanil, bupivacaine in prostate cancer (PCa), sponsored by Örebro University. Started Sep 2010; status: completed.

02

Drugs

ropivacainesufentanilbupivacaine
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT01367418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01367418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call